Metro Inc
TSX:MRU

Watchlist Manager
Metro Inc Logo
Metro Inc
TSX:MRU
Watchlist
Price: 99.97 CAD 0.09% Market Closed
Market Cap: 21.4B CAD

Metro Inc
Investor Relations

Metro Inc., a stalwart in the Canadian retail landscape, navigates the competitive corridors of the grocery and pharmaceutical sectors with precision and acumen. Founded in 1947, Metro has grown from a humble beginning in Quebec to a significant force across the provinces, marking its presence with an expansive network of supermarkets, discount stores, and pharmacy outlets. The company's operations are neatly divided into two main segments: food and pharmaceuticals. Metro's grocery segment operates under well-recognized banners such as Metro, Super C, and Food Basics, offering a diverse array of products ranging from fresh produce and meats to private-label merchandise. This segment’s success hinges on Metro’s ability to adapt to consumer tastes and utilize data-driven strategies for inventory management, thereby optimizing both the customer shopping experience and logistical efficiency.

Parallel to its grocery operations, Metro has built a robust pharmaceutical division through its affiliation with Jean Coutu and other pharmacy brands. This segment provides not only prescription medications but also a comprehensive suite of health, beauty, and wellness products. The synergy between the food and pharmaceutical divisions allows Metro to leverage cross-category shopping trends and customer loyalty programs, fostering a one-stop-shop format that resonates with its clientele. Revenue generation is anchored in the company's strategic pricing models, high-volume sales, and the continuous enhancement of private-label offerings, all orchestrated to maintain a balance between competitive pricing and profit margins. Through thoughtful expansions and acquisitions, Metro Inc. has crafted a diversified yet cohesive portfolio that drives sustainable growth and strengthens its positioning in the ever-evolving retail marketplace.

Show more
Loading
MRU
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Nov 19, 2025
AI Summary
Q4 2025

Revenue Growth: Metro reported fourth quarter sales of $5.1 billion, up 3.4% from last year, driven by gains in discount and pharmacy segments.

Gross Margin Improvement: Gross margin increased to 20% of sales, up from 19.7% last year, supported by better shrink and productivity gains.

DC Disruption Costs: The Toronto freezer shutdown cost Metro $22.5 million after tax in Q4, with another $15–20 million expected in Q1 due to contingency measures.

Pharmacy Strength: Pharmacy same-store sales rose 4.8%, with prescription sales up 5.5% and commercial sales up 2.9%.

EPS and Net Earnings: Adjusted net earnings grew 8.6% to $246 million, and adjusted EPS increased 10.8% to $1.13.

CapEx Outlook: Capital expenditures were $511 million in fiscal '25 and are expected to rise to about $550 million in fiscal '26.

Outlook Stable: Management sees Q1 trends similar to Q4, expects DC operations to normalize by year-end, and continues to focus on efficiency and discount store expansion.

Key Financials
Revenue
$5.1B
Food Same-Store Sales
1.6%
Pharmacy Same-Store Sales
4.8%
Prescription Sales Growth
5.5%
Front-End Pharmacy Sales Growth
2.9%
Gross Margin
$1.022B
Gross Margin Rate
20%
Operating Expenses
$535M
Operating Expenses as % of Sales
10.5%
EBITDA
$485M
Adjusted EBITDA
$491M
Adjusted EBITDA Margin
9.6%
Depreciation and Amortization
$140M
Net Financial Costs
$34.4M
Effective Tax Rate
24.1%
Adjusted Net Earnings
$246M
Adjusted EPS
$1.13
Capital Expenditures
$511M
Shares Repurchased
8.7M
Share Repurchase Amount
$848M
Average Share Price (Buyback)
$97.51
Net Increase in Retail Square Footage
294,000 sq ft
Online Sales Growth
19.8%
Clinical Services (Pharmacy)
5.4M
Earnings Call Recording
Other Earnings Calls

Management

Mr. Eric Richer La Fleche
President, CEO & Non-Independent Director
No Bio Available
Mr. Francois Thibault C.F.A.
Executive VP, CFO & Treasurer
No Bio Available
Mr. Carmen Fortino
Executive Vice President of National Supply Chain & Procurement
No Bio Available
Mr. Jean-Michel Coutu
President of Jean Coutu Group
No Bio Available
Mr. Frederic Legault
VP & Chief Information Officer
No Bio Available
Mr. Simon Rivet
VP, General Counsel & Corporate Secretary
No Bio Available
Ms. Marie-Claude Bacon
Vice President of Public Affairs & Communications
No Bio Available
Mr. Alain Tadros
VP, Chief Marketing & Digital Strategy Officer
No Bio Available
Ms. Geneviève Bich
Vice President of Human Resources
No Bio Available
Mr. Richard Beaubien
Senior Vice President of Store Operations - Ontario Division
No Bio Available

Contacts

Address
QUEBEC
MONTREAL
11011 Maurice-Duplessis
Contacts
+15146431000.0
www.metro.ca